Home / Medical Devices / Hemostasis And Tissue Sealing Agents Market By Product (Hemostats, Sealants, Adhesives) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Hemostasis And Tissue Sealing Agents Market By Product (Hemostats, Sealants, Adhesives) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Published: Aug 2018 | Report Code: 59282-08-18

Industry Outlook

Hemostasis and tissue sealing agents are material used for restricting bleeding or hemorrhage caused from injuries or during surgical procedures. Perpetual innovation in the field of hemostasis, and increased volume of surgical procedures together drive the growth of this market. Growth in the prevalence of chronic diseases and geriatric population has led to increased number of surgeries performed worldwide. Conditions such as cardiovascular diseases, hernia, ophthalmic conditions, gynecological and urological conditions, and burns frequently require surgical intervention wherein hemostats and tissue sealants are required.

Hemostats and tissue sealing agents are used for prevention of blood loss and have wide application in surgical procedures. Minimally invasive surgical interventions are particular areas where hemostats are frequently used. Therefore, growing trend of adoption of minimally invasive surgeries promote the growth of hemostasis and tissue sealing agents market. However, lack of widespread and appropriate reimbursement to these products restrains the desired market growth.

Market Synopsis

Hemostasis And Tissue Sealing Agents Market

Increasing Count of Surgical Procedures to Intensify the Market Growth

Based on the product types, the global hemostasis and tissue sealing agents market is categorized into hemostats, sealants and adhesives. The hemostats segment is further categorized as mechanical, active and flowable hemostats; sealants as fibrin and synthetic sealants; adhesives as Cyanoacrylate and, albumin and glutaraldehyde. Among these, hemostats segment enjoys the largest revenue share in the global market as these products offer greater cost efficiency, quick sealing properties and low tissue reactivity. Sealants and adhesives will witness rapid market growth during the forecast period on the ground of their proven efficiency in preventing blood loss from surgical sites in combination with other drugs. Growing demand of these products over surgical sutures is due to their faster application rate, less invasion, lower risk of infections and lesser exudate discharge. The market players engaged in production of hemostats and tissue sealing agents are engaged in production of novel agents that have wider applicability than the existing ones.  Furthermore, efforts are also being undertaken to bring innovation towards introducing natural sealants, which will have better bioavailability and therefore witness fast market growth.

Hemostasis And Tissue Sealing Agents Market

North America and Asia Pacific to Remain the Most Prominent Regional Markets

At present, North America has largest revenue contribution in the global hemostasis and tissue sealing agents market. High prevalence of chronic diseases such as diabetes, and cancer in the region promote the dominance of North America market. Europe is estimated as the second largest regional market as the region witnesses swift approval to novel and technologically advanced products in the healthcare system, along with greater incidence of surgical procedures. Aggressive marketing of novel surgical products to surgeons also facilitates the dominance of Europe and North America on the global front. Additionally, Asia Pacific is anticipated to undergo the fastest market growth during the forecast period from 2018 to 2026. Favorable government policies and increasing healthcare expenditure, along with large potential patient pool contribute to the swift pace of Asia Pacific market. The burgeoning medical tourism industry in the region also supports the market growth in Asia Pacific.

Hemostasis And Tissue Sealing Agents Market

Hemostasis And Tissue Sealing Agents Market

Historical & Forecast Period

2016 – Historical Year

2017 – Base Year

2018-2026 – Forecast Period

This research report presents the analysis of each considered segment for the period from 2016 to 2026, having 2017 as the base year for estimations. Compounded annual growth rates (CAGRs) for each segment are calculated for the forecast period from 2018 to 2026.

Hemostasis And Tissue Sealing Agents Market

Report Scope by Segments

This report on global hemostasis and tissue sealing agents market offers both qualitative and quantitative analysis of the industry in terms of market size and forecast and the prevalent market dynamics. For the purpose of this study, the global hemostasis and tissue sealing agents market is studies for product types and geography.

By Products (2016–2026; US$ Mn)

  • Hemostats
  • Mechanical
  • Active
  • Flowable
  • Sealants
  • Fibrin Sealants
  • Synthetic Sealants, PEG-based
  • Adhesives
  • Cyanoacrylate
  • Albumin and Glutaraldehyde

Geography Segment (2016–2026; US$ Mn)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • Japan
    • Rest of APAC
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • GCC
    • Rest of Middle East and Africa

The market dynamics in the hemostasis and tissue sealing agents industry are assessed for vivid understanding of the industry development. The dynamics for the global hemostasis and tissue sealing agents market are categorized into drivers, challenges, and opportunities. The report also includes competitive analysis of the prominent players in the global hemostasis and tissue sealing agents. The profiles of such players are also assessed in the study based on their business overview, product portfolio, financial information, and key developments. The prime players operating in the global hemostasis and tissue sealing agents market are Baxter International, Inc., Johnson & Johnson, CryoLife, Inc., Advanced Medical Solutions Group plc, Cohera Medical, Inc., Integra LifeSciences Corporation, Pfizer, Inc., C R Bard Inc., Cohesion Technologies, Inc., Zimmer Biomet, and B Braun Medical Inc.

Key questions answered in this report

  • What is the current status of the global hemostasis and tissue sealing agents market, and how the global market will progress through the forecast period?
  • What are the major market drivers, and challenges prevalent in the global hemostasis and tissue sealing agents market?
  • Which are the key market opportunities available for the market players to harness?
  • Where the tissue sealing agents market seen by 2026?
  • How are the major market players shaping their strategies for retaining or augmenting their competitive edge?
  • Which regional market will undergo the fastest market growth during the forecast period?
  • Will the positions of North America and Europe markets be challenged by the rapid advances of Asia Pacific market?
  • What is the current status of the competitive landscape of the global hemostasis and tissue sealing agents market?

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I – Secondary Research
1.4.2. Phase II – Primary Research
1.4.3. Phase III – Expert Panel Review
1.4.4. Assumptions
1.5. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Hemostasis and Tissue Sealing Agents Market Portraiture
2.2. Global Hemostasis and Tissue Sealing Agents Market, by Product, 2017 (US$ Mn)
2.3. Global Hemostasis and Tissue Sealing Agents Market, by Geography, 2017 (US$ Mn)

Chapter 3. Global Hemostasis and Tissue Sealing Agents Market: Dynamics and Future Outlook
3.1. Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Hemostasis and Tissue Sealing Agents Market, by Key Players, 2017

Chapter 4. Global Hemostasis and Tissue Sealing Agents Market, by Product, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Hemostats
4.2.1. Mechanical
4.2.2. Active
4.2.3. Flowable
4.3. Sealants
4.3.1. Fibrin Sealants
4.3.2. Synthetic Sealants, PEG-based
4.4. Adhesives
4.4.1. Cyanoacrylate
4.4.2. Albumin and Glutaraldehyde

Chapter 5. Global Hemostasis and Tissue Sealing Agents Market, by Geography, 2016 – 2026 (US$ Mn)
5.1. Overview
5.1.1. North America Hemostasis and Tissue Sealing Agents Market, 2016-2026 (US$ Mn)
5.1.2. North America Hemostasis and Tissue Sealing Agents Market, by Product, 2016 - 2026 (US$ Mn)
5.1.3. North America Hemostasis and Tissue Sealing Agents Market, by Country, 2016 – 2026 (US$ Mn)
5.1.3.1. U.S.
5.1.3.2. Canada
5.2. Europe Hemostasis and Tissue Sealing Agents Market, 2016 – 2026 (US$ Mn)
5.2.1. Europe Hemostasis and Tissue Sealing Agents Market, by Product, 2016 - 2026 (US$ Mn)
5.2.2. Europe Hemostasis and Tissue Sealing Agents Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.2.2.1. U.K.
5.2.2.2. Germany
5.2.2.3. Rest of Europe
5.3. Asia Pacific Hemostasis and Tissue Sealing Agents Market, 2016 – 2026 (US$ Mn)
5.3.1. Asia Pacific Hemostasis and Tissue Sealing Agents Market, by Product, 2016 - 2026 (US$ Mn)
5.3.2. Asia Pacific Hemostasis and Tissue Sealing Agents Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.3.2.1. China
5.3.2.2. Japan
5.3.2.3. Rest of Asia Pacific
5.4. Latin America Hemostasis and Tissue Sealing Agents Market, 2016 – 2026 (US$ Mn)
5.4.1. Latin America Hemostasis and Tissue Sealing Agents Market, by Product, 2016 - 2026 (US$ Mn)
5.4.2. Latin America Hemostasis and Tissue Sealing Agents Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.4.2.1. Brazil
5.4.2.2. Mexico
5.4.2.3. Rest of Latin America
5.5. Middle East & Africa Hemostasis and Tissue Sealing Agents Market, 2016 – 2026 (US$ Mn)
5.5.1. Middle East & Africa Hemostasis and Tissue Sealing Agents Market, by Product, 2016 - 2026 (US$ Mn)
5.5.2. Middle East & Africa Hemostasis and Tissue Sealing Agents Market, by Region, 2016 – 2026 (US$ Mn)
5.5.2.1. GCC
5.5.2.2. Rest of Middle East & Africa

Chapter 6. Company Profiles
6.1. Baxter International, Inc.
6.1.1. Business Description
6.1.2. Financial Information (Subject to Data Availability)
6.1.3. Product Portfolio
6.1.4. Key Developments
6.2. Johnson & Johnson
6.3. CryoLife, Inc.
6.4. Advanced Medical Solutions Group plc
6.5. Cohera Medical, Inc.
6.6. Integra LifeSciences Corporation
6.7. Pfizer, Inc.
6.8. C R Bard Inc.
6.9. Cohesion Technologies Inc
6.10. Zimmer Biomet
6.11. B Braun Medical Inc.

FIG 1. Hemostasis and Tissue Sealing Agents Market: Research Methodology
FIG 2. Hemostasis/Coagulation Analyzers: Market Segmentation
FIG 3. Global Hemostasis and Tissue Sealing Agents Market, by Product, 2017 (US$ Mn)
FIG 4. Global Hemostasis and Tissue Sealing Agents Market, by Geography, 2017 (US$ Mn)
FIG 5. Attractive Investment Proposition, by Geography, 2017
FIG 6. Competitive Analysis: Global Hemostasis and Tissue Sealing Agents Market, by Key Players, 2017
FIG 7. Global Mechanical Hemostats Market, 2016-2026(US$ Mn)
FIG 8. Global Active Hemostats Market, 2016-2026 (US$ Mn)
FIG 9. Global Flowable Hemostats Market, 2016-2026 (US$ Mn)
FIG 10. Global Fibrin Sealants Market, 2016-2026 (US$ Mn)
FIG 11. Global Synthetic Sealants, PEG-based Market, 2016-2026 (US$ Mn)
FIG 12. Global Cyanoacrylate Adhesives Market, 2016-2026 (US$ Mn)
FIG 13. Global Albumin and Glutaraldehyde Adhesives Market, 2016-2026 (US$ Mn)
FIG 14. U.S. Hemostasis and Tissue Sealing Agents Market, 2016-2026 (US$ Mn)
FIG 15. Canada Hemostasis and Tissue Sealing Agents Market, 2016-2026 (US$ Mn)
FIG 16. U.K. Hemostasis and Tissue Sealing Agents Market, 2016-2026 (US$ Mn)
FIG 17. Germany Hemostasis and Tissue Sealing Agents Market, 2016-2026 (US$ Mn)
FIG 18. Rest of Europe Hemostasis and Tissue Sealing Agents Market, 2016-2026 (US$ Mn)
FIG 19. China Hemostasis and Tissue Sealing Agents Market, 2016-2026 (US$ Mn)
FIG 20. Japan Hemostasis and Tissue Sealing Agents Market, 2016-2026 (US$ Mn)
FIG 21. Rest of Asia Pacific Hemostasis and Tissue Sealing Agents Market, 2016-2026 (US$ Mn)
FIG 22. Brazil Hemostasis and Tissue Sealing Agents Market, 2016-2026 (US$ Mn)
FIG 23. Mexico Hemostasis and Tissue Sealing Agents
FIG 24. Market, 2016-2026 (US$ Mn)
FIG 25. Rest of Latin America Hemostasis and Tissue Sealing Agents Market, 2016-2026 (US$ Mn)
FIG 26. GCC Hemostasis and Tissue Sealing Agents Market, 2016-2026 (US$ Mn)
FIG 27. Rest of Middle East and Africa Hemostasis and Tissue Sealing Agents Market, 2016-2026 (US$ Mn)

TABLE 1 Global Hemostasis and Tissue Sealing Agents Market Portraiture
TABLE 2 Global Hemostasis and Tissue Sealing Agents Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 3 Global Hemostats Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 4 Global Tissue Sealants Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 5 Global Tissue Adhesives Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 6 North America Hemostasis and Tissue Sealing Agents Market, by Product, 2016 – 2026 (US$ Mn
TABLE 7 North America Hemostasis and Tissue Sealing Agents Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe Hemostasis and Tissue Sealing Agents Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 9 Europe Hemostasis and Tissue Sealing Agents Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 10 Asia Pacific Hemostasis and Tissue Sealing Agents Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific Hemostasis and Tissue Sealing Agents Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 12 Latin America Hemostasis and Tissue Sealing Agents Market, by Product, 2016 – 2026 (US$ Mn
TABLE 13 Latin America Hemostasis and Tissue Sealing Agents Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Middle East and Africa Hemostasis and Tissue Sealing Agents Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 15 Middle East and Africa Hemostasis and Tissue Sealing Agents Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 16 Baxter International, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 17 Johnson & Johnson: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 18 CryoLife, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 19 Advanced Medical Solutions Group plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 20 Cohera Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Integra LifeSciences Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Pfizer, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 C R Bard Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Cohesion Technologies, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Zimmer Biomet: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 B Braun Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients